Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Korman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of the American Academy of Dermatology|March 18, 2018
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3Alexander Egeberg, Jashin J Wu, Neil Korman, et al.
Seminars in Arthritis and Rheumatism|June 11, 2015
Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS)Deepan S Dalal, Yih Chang Lin, Danielle M Brennan, et al.
Journal of the American Academy of Dermatology|October 30, 2017
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatmentKevin L Winthrop, Neil Korman, William Abramovits, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitisJon M Hanifin, Amy S Paller, Lawrence Eichenfield, et al.
Journal of Drugs in Dermatology : JDD|April 3, 2008
Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomesLeon Kircik, Jerry Bagel, Neil Korman, et al.
Pediatric Dermatology|January 31, 2013
Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United StatesKatherine Mercy, Mary Kwasny, Kelly M Cordoro, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of the American Academy of Dermatology|March 18, 2018
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3Alexander Egeberg, Jashin J Wu, Neil Korman, et al.
Seminars in Arthritis and Rheumatism|June 11, 2015
Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS)Deepan S Dalal, Yih Chang Lin, Danielle M Brennan, et al.
Journal of the American Academy of Dermatology|October 30, 2017
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatmentKevin L Winthrop, Neil Korman, William Abramovits, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitisJon M Hanifin, Amy S Paller, Lawrence Eichenfield, et al.
Journal of Drugs in Dermatology : JDD|April 3, 2008
Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomesLeon Kircik, Jerry Bagel, Neil Korman, et al.
Pediatric Dermatology|January 31, 2013
Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United StatesKatherine Mercy, Mary Kwasny, Kelly M Cordoro, et al.
Pageof 2